Displacement of BRD4 by BET inhibition relieves this repression, leaving p53 free to activate its pro-apoptotic targets, thereby accounting for the enhanced killing of AML by combined MDM2 and BET inhibition. Here, MDM2 is linked to acute myeloid leukemia.